Lanreotide Subcutaneous and SPB11
Determining the interaction of Lanreotide Subcutaneous and SPB11 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lanreotide
Brand name: Somatuline Depot
Synonyms: Lanreotide
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Sodium phenylbutyrate, Sodium Phenylbutyrate Powder
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lanreotide Subcutaneous-Specimen Collection Kit
- Lanreotide Subcutaneous-Spectazole
- Lanreotide Subcutaneous-Spectazole Topical
- Lanreotide Subcutaneous-Spectracef
- Lanreotide Subcutaneous-Spectro Tar Skin Wash Topical
- Lanreotide Subcutaneous-Spiriva
- SPB11-Lansoprazole
- SPB11-Lansoprazole Delayed-Release Capsules
- SPB11-Lansoprazole Orally Disintegrating Tablets
- SPB11-Lansoprazole, Amoxicillin, and Clarithromycin
- SPB11-Lanthanum
- SPB11-Lanthanum carbonate